Clinical questions routed to specialist models
OpenEvidence coordinates medically specialized models through a central system that routes each question to the relevant clinical expertise. Content partnerships include the New England Journal of Medicine, the American Medical Association and the National Comprehensive Cancer Network.
A free, advertising-supported service
Verified clinicians use the platform without a subscription charge. The Series D values the business at $12 billion; the announcement names Thrive Capital and DST Global as co-leads but does not identify exactly which earlier backers joined this round.